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RECOMMENDATIONS FROM A MEETING ON HEALTH IMPLICA-
TIONS OF GENETICALLY MODIFIED ORGANISM (GMO) 





The Ghana Public Health Association organized a sci-
entific seminar to examine the introduction of genet-
ically modified organisms into public use and the 
health consequences. The seminar was driven by cur-
rent public debate on the subject. The seminar identi-
fied some of the advantages of GMOs and also the 
health concerns. It is clear that there is the need to en-
hance local capacity to research the introduction and 
use of GMOs; to put in place appropriate regulatory 
mechanisms including particularly the labeling of 
GMO products and post-marketing surveillance for 
possible negative health consequences in the long term. 
Furthermore the appropriate state agency should put in 




There is universal agreement that the world’s popula-
tion is increasing at an alarming rate especially in de-
veloping countries and this poses a major threat to food 
security. The United Nations projects that world popu-
lation will increase by 25% to 7.5 billion by 2020. 
Climate change is likely to worsen available food sup-
plies which may lead to malnutrition and other serious 
health problems. 
 
To address these concerns, Genetically Modified Or-
ganisms (GMOs) have been introduced to improve 
food production. According to the EU, a Genetically 
Modified Organism is any organism, with the excep-
tion of human beings, in which the genetic material has 
been altered in a way that does not occur naturally by 
mating and/or natural recombination. Genetically Mod-
ified (GM) products include medicines and vaccines, 
foods and food ingredients, feeds, and fibers. As of 
August 2012, the United States of America Food and 
Drugs Administration has approved a total of 144 
crops, including corn, soy, cotton, canola, potato, 
squash and tomato, for commercialization. 
 
In Ghana, the Biosafety Act (2011), Act 831,was 
passed to establish the National Biosafety Authority 
with the objective of, inter alia, “to ensure an adequate 
level of protection in the field of safe development, 
transfer, handling and use of genetically modified or-
ganisms resulting from biotechnology that may have an 
adverse effect on health and the environment”.  
The law therefore allows the application of biotechnol-
ogy in food crop production. The Act does not apply to 
“genetically modified organisms that are pharmaceuti-
cal for human use”. 
 
The Plant Breeders bill laid in Parliament on the 28th 
day of May, 2013 on the other hand seeks among oth-
ers to provide for the grant and protection of plant 
breeder rights. This bill has generated such controversy 
that it has been withdrawn pending further consulta-
tion. 
 
Biotechnological tools have been used to modify agri-
cultural produce in Ghana’s agricultural research insti-
tutes contributing to better yields, pest and weather 
resistance 
 
There has been widespread controversy generated 
worldwide, Ghana included, since the introduction of 
GM crops, especially after commercialization of the 
products. Concerns have been raised about GM crops 
for a variety of reasons including Ethical, Biosafety 
(Environmental impact, Health), Bioproperty, and Bio-
politics considerations.    
 
It is in this context that the Ghana Public Health Asso-
ciation (GPHA) organized a public scientific lecture on 
GMOs and its health implications on 3rd April 2014 to 
understand the science behind the technology and dis-
cuss its public health implications to inform policy. 
GPHA is an apolitical, non-governmental professional 
association of all interested professionals who have a 
contribution to make to improve public health in Gha-
na.  
 
Experts from the College of Agriculture and Consumer 
Sciences of the University of Ghana, Legon, and Na-
tional Public Health Surveillance Department of Ghana 
Health Service presented carefully researched scientific 
papers on the subject, followed by thorough dispas-














SYNTHESIS OF ISSUES 
The presentations and discussions resulted in the eluci-




Some of the advantages and potential health benefits 
include the following: 
 
• Introduction of pest resistant, herbicide tolerant, 
disease resistant,  cold  tolerant,  and  drought tol-
erant crops with potential for increased crop yield. 
• Potential for reduced use of chemicals and pesti-
cides on insect resistant plants, which will result in 
healthier food 
• Improving the nutritional properties of crops to 
enhance human health through food fortification 
with desired vitamins and minerals 
• GMOs provide huge potential for production of 
pharmaceuticals and vaccines which will be much 
easier to ship, store and administer than traditional 
injectable vaccines. 
• Use of technology for Gene therapy - direct use of 
DNA to treat disease 
• Application in stem cell research - the manipula-
tion of undifferentiated cells to replace damaged or 
diseased tissues in the body 
 
CONCERNS 
Notwithstanding the advantages and major potential 
public health benefits, a number of concerns and poten-
tial negative health impact were identified: 
• Current efforts are focused primarily on a few 
crop/trait combinations that have high commercial 
value and occupy large international markets, 
hence are primarily profit driven 
• Public Institutions are resource limited and lack 
infrastructure and capacity to compete; there is 
poor access to advanced technology and weak reg-
ulatory capacity in country. 
• Potential for unpredictable, unintended mutations 
in the organism with consequential medico-legal 
events. 
• Tendency to provoke allergic reactions. New pes-
ticide residue effects in alimentary system may af-
fect gut bacteria provoking peripheral immune and 
allergic reactions.  
• Lack of labeling of GMO products hinders post-
marketing surveillance of the GMO products for 
safety.  
• Most of the trials supporting introduction of 
GMOs are not independently done and are com-
mercially driven. The trial designs are laboratory 
design and of short duration.  Short-term studies 
may mask chronic toxicological effects including 
later developmental and reproductive effects.  
• Increasing trends in organ disease and GMOs use 
have been observed. There is some correlation be-
tween organ disease, increasing GMO in food sup-
ply, and glyphosate herbal application with possi-
bility of endocrine disruption. Organ disease men-
tioned include: Thyroid cancer; Liver and Intra he-
patic bile duct cancer; Hypertension; Acute kidney 
disease; Diabetes mellitus; Autism; Alzheimer’s 
disease; Parkinson's disease; Senile dementia; In-
flammatory bowel disease – Crohn’s and Ulcera-
tive colitis; Rheumatoid arthritis. Though these 
have not been proven yet there is need to keep an 
eye on the correlation through further observation-
al and epidemiological studies. 
 
CONCLUSIONS, RECOMMENDATIONS 
AND WAY FORWARD 
1. There is great potential to improve health, nutrition 
and food security through GMOs and Ghana 
should place itself appropriately to benefit maxi-
mally from the technology. 
2. However, there is need to be cautious and move 
slowly. The development, testing and release of 
GMO products must be appropriately regulated. 
This calls for regulatory structures that ensure that 
there is no harm to humans, animals and the envi-
ronment. The current systems in place are not ade-
quate and capable to perform these critical func-
tions. 
3. Protocols for new GMO trials and release of GMO 
crops should be transparently reviewed by inde-
pendent national regulatory body before approval. 
4. The regulatory, clinical trial and post-marketing 
monitoring and surveillance capacities in the coun-
try should be strengthened. Universities and Re-
search institutions should therefore be supported 
and equipped in the area of biotechnology. 
5. There is need for longer, more-detailed transparent 
toxicological tests on all GMOs before approval 
and release to the market.  
6. All GMOs must be appropriately labeled as such 
for informed choice and to facilitate post-market 
monitoring of any health effects  
 
POLICY OPTIONS/ DIRECTIONS 
1. The Biosafety Act (2011), Act 831, which has al-
ready been passed, can be maintained and an ap-
propriate Legislative Instrument developed with 
wide consultations to take care of the health con-
cerns and other conclusions and recommendations 
listed above. 
2. Another option is to withdraw the Biosafety Act, if 
possible, for review to ensure that the recommen-
 
 





dations and health concerns are taken care of in a 
new parent Biosafety Act.   
3. Another option is to incorporate the health con-
cerns and recommendations in the proposed Plant 
Breeders bill as appropriate. 
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